Pubblicazioni scientifiche sui diagnostici non invasivi BioPredictive

Studi sottoposti a revisione paritaria che convalidano i diagnostici ematici BioPredictive per le malattie del fegato — dalle coorti di sviluppo pionieristiche alle meta-analisi a lungo termine.

10/434 Risultati per
“DAA, direct-acting antivirals”

“DAA, direct-acting antivirals” Cancella tutto

  1. External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV.

    Poynard T et al. · JHEP Rep · 2021 Punteggio 100

    …CHC) treated or not with antivirals. ### Methods Pre-included patients were from…

    LCR1 LCR2 HCV

  2. Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis.

    Asselah T et al. · Liver Int · 2018 Punteggio 95

    ### Background & Aims Patients with chronic hepatitis C virus infection and advanced fibrosis…

    FibroTest HCV

  3. Management of the patient with SVR. Review

    Terrault NA et al. · J Hepatol · 2016 Punteggio 90

    In the current era of therapy with direct-acting antiviral (DAAs) drugs…

    FibroTest HCV

  4. Real-world efficacy and safety of ombitasvir, paritaprevir/r+dasabuvir+ribavirin in genotype 1b patients with hepatitis C virus cirrhosis.

    Preda CM et al. · Liver Int · 2018 Punteggio 85

    ### Background Direct antiviral agents (DAA) showed very good results in terms of…

    FibroTest HCV

  5. HIV-positive men who have sex with men are at high risk of development of significant liver fibrosis after an episode of acute hepatitis C.

    Steininger K et al. · J Viral Hepat · 2017 Punteggio 80

    …New direct-acting antiviral agent (DAA) combination therapy has not yet been…

    FibroTest HCV HIV

  6. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Key publication

    AASLD/IDSA HCV Guidance Panel · Hepatology · 2015 Punteggio 75

    ActiTest FibroTest HCV

  7. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

    Terrault NA et al. · Hepatology · 2018 Punteggio 70

    ActiTest FibroTest HBV

  8. External Validation of LCR1-LCR2, a Multivariable Hepatocellular Carcinoma Risk Calculator, in a Multiethnic Cohort of Patients With Chronic Hepatitis B.

    Poynard T et al. · Gastro Hep Adv · 2022 Punteggio 65

    …after adjustment for exposure to antivirals, age, gender, geographical origin, HBe-Ag…

    FibroTest LCR1 LCR2 Surveillance-FibroTest +1

  9. Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection Key publication

    · 2014 Punteggio 60

    These are the first guidelines dealing with hepatitis C treatment produced by…

    FibroTest HCV

  10. Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference.

    Munteanu M et al. · Aliment Pharmacol Ther · 2016 Punteggio 55

    ### Background Blood tests of liver injury are less well validated in non…

    ActiTest FibroTest SteatoTest Metabolic

Mostra l'elenco completo dei risultati. La pagina è renderizzata sul server e non è paginata.